日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative theranostic efficacy of (177)Lu- and (161)Tb-labeled A1K2 SdAb in mesothelin-positive tumors

(177)Lu 和(161)Tb 标记的 A1K2 SdAb 在间皮素阳性肿瘤中的治疗诊断效果比较

N'Guessan, Émilien; Raes, Florian; Ahmadi, Mitra; Bacot, Sandrine; Dumas, Laurent; Leenhardt, Julien; du Moulinet d'Hardemare, Amaury; Debiossat, Marlène; André, Clémence; Boutonnat, Jean; Durivault, Jérôme; Montemagno, Christopher; Lenormand, Jean-Luc; Djaïleb, Loïc; Köster, Ulli; Van de Voorde, Michiel; Ramaekers, Stijn; Verguts, Ken; Ghezzi, Catherine; Perret, Pascale; Lombardi, Charlotte; Broisat, Alexis

Neural Innervation of Tumors: Mechanisms, Hallmarks, and Therapeutic Opportunities

肿瘤的神经支配:机制、特征和治疗机会

Cassim, Shamir; Montemagno, Christopher

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

开发和验证 PSMA 阳性三阴性乳腺癌小鼠模型,用于临床前靶向放射性核素治疗。

Chaussin Benjamin, Sanchez Lucie, Levesque Sophie, Revy Alban, Tempier Marion, Montemagno Christopher, Durivault Jérôme, Schmitt Sébastien, Boutault Erwan, Besse Sophie, Chautard Emmanuel, Auriol Manon, Voissiere Aurélien, Kossaï Myriam, Miot-Noirault Elisabeth, Penault-Llorca Frédérique, Merlin Charles, Cachin Florent, Jouberton Elodie

From Seeing to Healing: The Clinical Potential of Radiotracers in Pediatric Neuro-Oncology

从观察到治愈:放射性示踪剂在儿科神经肿瘤学中的临床应用潜力

Bogdanović, Bojana; Montemagno, Christopher

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy

血液系统恶性肿瘤的诊疗一体化:诊断和靶向治疗的前沿进展

Bogdanovic, Bojana; Hugonnet, Florent; Montemagno, Christopher

Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model.

针对转移性黑色素瘤中的黑色素异质性:双肿瘤小鼠黑色素瘤模型

Delmas Marine, Chaussin Benjamin, Harismendy Nathan, Dougé Aurore, Rouzaire Paul-Olivier, Montemagno Christopher, Durivault Jérôme, Moreau Emmanuel, Miot-Noirault Elisabeth, Quintana Mercedes, Besse Sophie, D'Incan Michel, Chautard Emmanuel, Jouberton Elodie, Rouanet Jacques

Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine-Glycine-Aspartate) Strategies

整合素靶向及其他:利用双靶向RGD(精氨酸-甘氨酸-天冬氨酸)策略增强癌症治疗

Bogdanović, Bojana; Fagret, Daniel; Ghezzi, Catherine; Montemagno, Christopher

Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?

阿尔茨海默病和帕金森病中自溶酶体去酸化缺陷的证据是否应该提示我们在长期处方PPI和DMARD时要谨慎?

Giuliano, Sandy; Montemagno, Christopher; Domdom, Marie-Angela; Teisseire, Manon; Brest, Patrick; Klionsky, Daniel J; Hofman, Paul; Pagès, Gilles; Mograbi, Baharia

Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future

核医学临床前研究的最新进展:开创无限未来之路

Echavidre, William; Fagret, Daniel; Faraggi, Marc; Picco, Vincent; Montemagno, Christopher

Quantitative analysis of (99m)Tc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions

利用大视野 CZT 伽玛相机对 (99m)Tc-高锝酸盐甲状腺摄取进行定量分析:可行性及 SPECT/CT 与平面采集的比较

Serrano, Benjamin; Amblard, Régis; Beaumont, Tiffany; Hugonnet, Florent; Dietz, Matthieu; Berthier, Frédéric; Garnier, Nicolas; Villeneuve, Rémy; Nataf, Valérie; Mocquot, François; Montemagno, Christopher; Faraggi, Marc; Paulmier, Benoît